An elevated level of α-Syn may activate glycogen synthase kinase (GSK-3β) [116], which is involved in tau hyperphosphorylation in neurodegenerative pathologies, particularly in AD [117], representing an additional potential link between T2DM and neuronal proteinopathies. The gene discussed is MAPT; the disease is type 2 diabetes mellitus.